Cargando…

Hepcidin levels in diabetes mellitus and polycystic ovary syndrome

AIM: Increased body iron is associated with insulin resistance. Hepcidin is the key hormone that negatively regulates iron homeostasis. We hypothesized that individuals with insulin resistance have inadequate hepcidin levels for their iron load. METHODS: Serum concentrations of the active form of he...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sam, A H, Busbridge, M, Amin, A, Webber, L, White, D, Franks, S, Martin, N M, Sleeth, M, Ismail, N A, Daud, N Mat, Papamargaritis, D, Le Roux, C W, Chapman, R S, Frost, G, Bloom, S R, Murphy, K G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Ltd 2013
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232927/ https://www.ncbi.nlm.nih.gov/pubmed/23796160 http://dx.doi.org/10.1111/dme.12262

Ejemplares similares

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Circulating Pancreatic Polypeptide Concentrations Predict Visceral and Liver Fat Content
por: Sam, Amir H., et al.
Publicado: (2015)

Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity
por: Couto Alves, A, et al.
Publicado: (2017)

Hair cortisol in polycystic ovary syndrome
por: Gonzalez, D., et al.
Publicado: (2022)

Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies
por: Barber, Thomas M, et al.
Publicado: (2019)

Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race/Ethnicity
por: Wolf, Wendy M., et al.
Publicado: (2018)

Bone mineral density in women with polycystic ovary syndrome
por: Katulski, K., et al.
Publicado: (2014)

Adiponectin and Its Receptors in the Ovary: Further Evidence for a Link between Obesity and Hyperandrogenism in Polycystic Ovary Syndrome
por: Comim, Fabio V., et al.
Publicado: (2013)

Cutaneous manifestation of polycystic ovary syndrome
por: Abusailik, Mohammad A., et al.
Publicado: (2021)

The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents
por: Psichas, A, et al.
Publicado: (2015)

Pathophysiology and Nutritional Approaches in Polycystic Ovary Syndrome (PCOS): A Comprehensive Review
por: Di Lorenzo, M., et al.
Publicado: (2023)

The Lifestyle Modifications and Endometrial Proteome Changes of Women With Polycystic Ovary Syndrome and Obesity
por: Abdulkhalikova, D., et al.
Publicado: (2022)

Mitochondrial Dysfunction and Chronic Inflammation in Polycystic Ovary Syndrome
por: Dabravolski, Siarhei A., et al.
Publicado: (2021)

Hepcidin secretion was not directly proportional to intracellular iron-loading in recombinant-TfR1 HepG2 cells: short communication
por: Mehta, Kosha J., et al.
Publicado: (2020)

SAT663 Determination Of Mitochondrial DNA Mass In Women With Polycystic Ovary Syndrome
por: Rojo, Mailén, et al.
Publicado: (2023)

Hemorrhage-Adjusted Iron Requirements, Hematinics and Hepcidin Define Hereditary Hemorrhagic Telangiectasia as a Model of Hemorrhagic Iron Deficiency
por: Finnamore, Helen, et al.
Publicado: (2013)

Features of Polycystic Ovary Syndrome in adolescence
por: Tsikouras, P, et al.
Publicado: (2015)

Effects of distinct Polycystic Ovary Syndrome phenotypes on bone health
por: Mills, Edouard G., et al.
Publicado: (2023)

Schizophrenia And Polycystic Ovary Syndrome: A Case Report
por: Turki, M., et al.
Publicado: (2022)

Hepcidin-25 in Diabetic Chronic Kidney Disease Is Predictive for Mortality and Progression to End Stage Renal Disease
por: Wagner, Martin, et al.
Publicado: (2015)

Polycystic ovary syndrome management: a review of the possible amazing role of berberine
por: Rondanelli, M., et al.
Publicado: (2020)

Epidemiology, diagnosis, and management of polycystic ovary syndrome
por: Sirmans, Susan M, et al.
Publicado: (2013)

Inflammatory Markers in Women with Polycystic Ovary Syndrome
por: Rudnicka, E., et al.
Publicado: (2020)

Insulin resistance and fertility in polycystic ovary syndrome.
por: Fica, S, et al.
Publicado: (2008)

Participation of the Cholinergic System in the Development of Polycystic Ovary Syndrome
por: Linares, Rosa, et al.
Publicado: (2021)

Genetic Rodent Models of Obesity-Associated Ovarian Dysfunction and Subfertility: Insights into Polycystic Ovary Syndrome
por: Huang-Doran, Isabel, et al.
Publicado: (2016)

Live birth rate after human chorionic gonadotropin priming in vitro maturation in women with polycystic ovary syndrome
por: Ho, V. N. A., et al.
Publicado: (2018)

Immune Dysfunction in Polycystic Ovary Syndrome
por: Banerjee, Soma, et al.
Publicado: (2023)

Insights into Manipulating Postprandial Energy Expenditure to Manage Weight Gain in Polycystic Ovary Syndrome
por: Siemienowicz, Katarzyna, et al.
Publicado: (2020)

Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis
por: Wojciechowski, P., et al.
Publicado: (2012)

Recent advances in the understanding and management of polycystic ovary syndrome
por: Rocha, Ana L., et al.
Publicado: (2019)

Intersection of Polycystic Ovary Syndrome and the Gut Microbiome
por: Rizk, Maryan G, et al.
Publicado: (2020)

Evidence From Men for Ovary-independent Effects of Genetic Risk Factors for Polycystic Ovary Syndrome
por: Zhu, Jia, et al.
Publicado: (2021)

Could perturbed fetal development of the ovary contribute to the development of polycystic ovary syndrome in later life?
por: Hartanti, Monica D., et al.
Publicado: (2020)

Erratum to: Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis
por: Wojciechowski, P., et al.
Publicado: (2012)

An Evolutionary Model for the Ancient Origins of Polycystic Ovary Syndrome
por: Dumesic, Daniel A., et al.
Publicado: (2023)

The Polycystic Ovary Syndrome: An update on metabolic and hormonal mechanisms
por: Dumitrescu, R, et al.
Publicado: (2015)

Identification of subjects with polycystic ovary syndrome using electronic health records
por: Castro, Victor, et al.
Publicado: (2015)

Endocrine Responses to Triptorelin in Healthy Women, Women With Polycystic Ovary Syndrome, and Women With Hypothalamic Amenorrhea
por: Abbara, Ali, et al.
Publicado: (2023)

An update of polycystic ovary syndrome: causes and therapeutics options
por: Rababa’h, Abeer M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4o84fsm679l411juar4f17ogb7